Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Successful treatment of a patient with tumor necrosis factor receptor-associated periodic syndrome using a half-dose of etanercept.

Kusuhara K, Hoshina T, Saito M, Ishimura M, Inoue H, Horiuchi T, Sato T, Hara T.

Pediatr Int. 2012 Aug;54(4):552-5. doi: 10.1111/j.1442-200X.2011.03525.x.

PMID:
22830546
2.

Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives.

Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG, Simonini G, Cimaz R.

Autoimmun Rev. 2012 Nov;12(1):38-43. doi: 10.1016/j.autrev.2012.07.020. Epub 2012 Aug 2. Review.

PMID:
22884554
3.

Tumor necrosis factor receptor 1-associated periodic syndrome without fever: cytokine profile before and during etanercept treatment.

Morbach H, Richl P, Stojanov S, Lohse P, Girschick HJ.

Rheumatol Int. 2009 Dec;30(2):207-12. doi: 10.1007/s00296-009-0937-0.

PMID:
19381634
4.

Recurrent abdominal pain as the presentation of tumor necrosis factor receptor-associated periodic syndrome (TRAPS) in an Asian girl: a case report and review of the literature.

Chen YJ, Yu HH, Yang YH, Lau YL, Lee WI, Chiang BL.

J Microbiol Immunol Infect. 2014 Dec;47(6):550-4. doi: 10.1016/j.jmii.2012.07.003. Epub 2012 Aug 24. Review.

5.

Role of etanercept in the treatment of tumor necrosis factor receptor-associated periodic syndrome: personal experience and review of the literature.

Cantarini L, Rigante D, Lucherini OM, Cimaz R, Laghi Pasini F, Baldari CT, Benucci M, Simonini G, Di Sabatino V, Brizi MG, Galeazzi M.

Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):701-7.

PMID:
20943039
6.

[Progress in classification and treatment for TNF receptor-associated periodic syndrome].

Tsukamoto H, Ueda N, Horiuchi T.

Nihon Rinsho Meneki Gakkai Kaishi. 2011;34(5):361-8. Review. Japanese.

7.

Tumour necrosis factor receptor-associated periodic syndrome caused by a rare mutation in the TNFRSF1A gene, and with excellent response to etanercept treatment.

Cantarini L, Lucherini OM, Galeazzi M, Fanti F, Simonini G, Baldari CT, Laghi Pasini F, De Martino M, Cimaz R.

Clin Exp Rheumatol. 2009 Sep-Oct;27(5):890-1. No abstract available.

PMID:
19917181
8.

Tumor necrosis factor receptor-associated periodic fever syndrome in a 58-year-old man: caution not to discount TRAPS as a diagnosis in older patients.

Sinožić D, Toplak N, Milotić I.

J Clin Rheumatol. 2011 Sep;17(6):325-8. doi: 10.1097/RHU.0b013e31822e092c.

PMID:
21869706
9.

Advances in the diagnosis and treatment of tumor necrosis factor receptor-associated periodic syndrome.

Aguado-Gil L, Irarrazaval-Armendáriz I, Pretel-Irazabal M.

Actas Dermosifiliogr. 2013 Sep;104(7):617-22. doi: 10.1016/j.adengl.2012.11.020. Epub 2013 Jul 23. Review.

PMID:
23891452
10.
11.

Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A.

Nedjai B, Quillinan N, Coughlan RJ, Church L, McDermott MF, Hitman GA, Turner MD.

Adv Exp Med Biol. 2011;691:409-19. doi: 10.1007/978-1-4419-6612-4_43. No abstract available.

PMID:
21153346
12.

A Case Presenting with the Clinical Characteristics of Tumor Necrosis Factor (TNF) Receptor-associated Periodic Syndrome (TRAPS) without TNFRSF1A Mutations Successfully Treated with Tocilizumab.

Hosoya T, Mizoguchi F, Hasegawa H, Miura K, Koike R, Kubota T, Miyasaka N, Kohsaka H.

Intern Med. 2015;54(16):2069-72. doi: 10.2169/internalmedicine.54.3371. Epub 2015 Aug 15.

13.

Hyper IgD syndrome (HIDS) associated with in vitro evidence of defective monocyte TNFRSF1A shedding and partial response to TNF receptor blockade with etanercept.

Arkwright PD, McDermott MF, Houten SM, Frenkel J, Waterham HR, Aganna E, Hammond LJ, Mirakian RM, Tomlin PI, Vijaydurai PI, Cant AJ.

Clin Exp Immunol. 2002 Dec;130(3):484-8.

14.

TNF receptor-associated periodic syndrome (TRAPS): description of a novel TNFRSF1A mutation and response to etanercept.

Jesus AA, Oliveira JB, Aksentijevich I, Fujihira E, Carneiro-Sampaio MM, Duarte AJ, Silva CA.

Eur J Pediatr. 2008 Dec;167(12):1421-5. doi: 10.1007/s00431-008-0685-2. Epub 2008 Apr 12.

PMID:
18408954
15.

Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome.

Rigante D, Lopalco G, Vitale A, Lucherini OM, De Clemente C, Caso F, Emmi G, Costa L, Silvestri E, Andreozzi L, Iannone F, Galeazzi M, Cantarini L.

Clin Rheumatol. 2014 Sep;33(9):1197-207. doi: 10.1007/s10067-014-2722-z. Epub 2014 Jun 17. Review.

PMID:
24935411
16.

A novel TNFRSF1 gene mutation in a Turkish family: a report of three cases.

Cosan F, Yazici A, Yılmazer B, Gul A, Ustek D, Cefle A.

Clin Rheumatol. 2013 Mar;32 Suppl 1:S83-5. doi: 10.1007/s10067-010-1507-2. Epub 2010 Jun 10.

PMID:
20532935
17.

The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder.

Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL.

Medicine (Baltimore). 2002 Sep;81(5):349-68. Review.

18.

A pro-inflammatory signalome is constitutively activated by C33Y mutant TNF receptor 1 in TNF receptor-associated periodic syndrome (TRAPS).

Negm OH, Mannsperger HA, McDermott EM, Drewe E, Powell RJ, Todd I, Fairclough LC, Tighe PJ.

Eur J Immunol. 2014 Jul;44(7):2096-110. doi: 10.1002/eji.201344328. Epub 2014 Jun 10.

20.

Supplemental Content

Support Center